These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 33590886)
1. Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915-918. Gando A; Alexay S; Galán Núñez JP; Cano LN; Diez RA; Costa LA J Med Virol; 2021 May; 93(5):2626-2627. PubMed ID: 33590886 [No Abstract] [Full Text] [Related]
2. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? Hadadi A; Mortezazadeh M; Kolahdouzan K; Alavian G J Med Virol; 2020 Jul; 92(7):915-918. PubMed ID: 32270515 [TBL] [Abstract][Full Text] [Related]
3. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days. Donato AA Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054 [TBL] [Abstract][Full Text] [Related]
4. Best practice statements and recommendations for caring for critically ill patients with COVID-19. Dugar SP; Vallabhajosyula S Ann Intern Med; 2020 Jun; 172(12):JC62. PubMed ID: 32539521 [TBL] [Abstract][Full Text] [Related]
5. Re: 'Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review' by Serafim et al. Lipes J; Yang SS Clin Microbiol Infect; 2021 Jun; 27(6):938-939. PubMed ID: 33484842 [No Abstract] [Full Text] [Related]
6. Comment on: "Care for critically ill patients with COVID-19: don't forget the eyes". Myint K; Lee D; Pringle E Eye (Lond); 2021 Jun; 35(6):1775-1776. PubMed ID: 32661338 [No Abstract] [Full Text] [Related]
7. Re: "High prevalence of heterotopic ossification in critically ill patients with severe COVID-19" by Stoira et al. de l'Escalopier N; Mathieu L; Duret C; Banzet S; Genêt F; Salga M Clin Microbiol Infect; 2021 Jul; 27(7):1051-1052. PubMed ID: 33460830 [No Abstract] [Full Text] [Related]
8. Letter to the Editor in response to Chen et al. 2020. Ponnampalam J; Seligmann G; Gandhi T; Parmar D Respir Res; 2020 Nov; 21(1):315. PubMed ID: 33256816 [TBL] [Abstract][Full Text] [Related]
9. Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection. Corrêa TD; Matos GFJ; Bravim BA; Cordioli RL; Garrido ADPG; Assuncao MSC; Barbas CSV; Timenetsky KT; Rodrigues RDR; Guimarães HP; Rabello Filho R; Lomar FP; Scarin FCC; Batista CL; Pereira AJ; Guerra JCC; Carneiro BV; Nawa RK; Brandão RM Einstein (Sao Paulo); 2020; 18():eCE5931. PubMed ID: 32785567 [No Abstract] [Full Text] [Related]
10. Letter in response to: Alamer A, Alrashed AA, Alfaifi M, et al. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin. 2021;19:1-13. DOI: 10.1080/03007995.2021.1920900. Dhanasekaran S; Chinnairusan M; Kagithakara Vajravelu L Curr Med Res Opin; 2022 Mar; 38(3):355-356. PubMed ID: 34933646 [No Abstract] [Full Text] [Related]
11. Comment on "Gastrointestinal Complications in Critically Ill Patients With COVID-19". Aguila EJT; Lontok MAD; Raymundo NTV Ann Surg; 2021 Dec; 274(6):e819-e820. PubMed ID: 32740252 [No Abstract] [Full Text] [Related]
12. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support. Donato AA Ann Intern Med; 2021 Dec; 174(12):JC134. PubMed ID: 34871053 [TBL] [Abstract][Full Text] [Related]
13. Reply to Wengenmayer Monnier A; Falcoz PE; Helms J; Meziani F Am J Respir Crit Care Med; 2020 Nov; 202(10):1479-1480. PubMed ID: 32795240 [No Abstract] [Full Text] [Related]
14. Addendum: Early triage of critically ill COVID-19 patients using deep learning. Liang W; Yao J; Chen A; Lv Q; Zanin M; Liu J; Wong S; Li Y; Lu J; Liang H; Chen G; Guo H; Guo J; Zhou R; Ou L; Zhou N; Chen H; Yang F; Han X; Huan W; Tang W; Guan W; Chen Z; Zhao Y; Sang L; Xu Y; Wang W; Li S; Lu L; Zhang N; Zhong N; Huang J; He J Nat Commun; 2021 Feb; 12(1):826. PubMed ID: 33526778 [No Abstract] [Full Text] [Related]
15. Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality. Ziadi A; Hachimi A; Admou B; Hazime R; Brahim I; Douirek F; Zarrouki Y; El Adib AR; Younous S; Samkaoui AM Int J Lab Hematol; 2021 Feb; 43(1):e38-e40. PubMed ID: 32996680 [No Abstract] [Full Text] [Related]
16. Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19-There Is No "Me" in COVID. Rubinson L JAMA Netw Open; 2021 Jan; 4(1):e2035041. PubMed ID: 33464314 [No Abstract] [Full Text] [Related]
17. Critically ill patients with COVID-19 and candidaemia: We must keep this in mind. Agrifoglio A; Cachafeiro L; Figueira JC; Añón JM; García de Lorenzo A J Mycol Med; 2020 Dec; 30(4):101012. PubMed ID: 32651137 [No Abstract] [Full Text] [Related]
18. Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity. Torres-Machorro A; Anguiano-Álvarez VM; Grimaldo-Gómez FA; Rodríguez-Zanella H; Cortina de la Rosa E; Mora-Canela S; Lerma C; García-Cruz E; Ramos-Enriquez Á; Ramirez-Marroquin S; Izaguirre-Ávila R; Rojas-Velasco G Thromb Res; 2020 Dec; 196():268-271. PubMed ID: 32927400 [TBL] [Abstract][Full Text] [Related]
19. Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?". Suárez-Pérez L; Coto-Hernández R; Suárez-Cuervo C; Caminal-Montero L J Intern Med; 2021 Mar; 289(3):425-426. PubMed ID: 32909292 [No Abstract] [Full Text] [Related]